168 related articles for article (PubMed ID: 38672378)
1. Effect of Melatonin on Chemoresistance Exhibited by Spheres Derived from Canine Mammary Carcinoma Cells.
Cataldo D; Aravena G; Escobar A; Tapia JC; Peralta OA; Torres CG
Animals (Basel); 2024 Apr; 14(8):. PubMed ID: 38672378
[TBL] [Abstract][Full Text] [Related]
2. Melatonin decreases in vitro viability and migration of spheres derived from CF41.Mg canine mammary carcinoma cells.
Serrano C; Guzmán S; Arias JI; Torres CG
BMC Vet Res; 2019 Nov; 15(1):390. PubMed ID: 31684950
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin exhibits antiproliferative effects on spheres derived from canine mammary carcinoma cells.
Torres CG; Olivares A; Stoore C
Oncol Rep; 2015 May; 33(5):2235-44. PubMed ID: 25778435
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin modulates β-catenin/MDR1 expression on spheres derived from CF41.Mg canine mammary carcinoma cells.
Cruz P; Reyes F; Torres CG
Pol J Vet Sci; 2018 Mar; 21(1):95-99. PubMed ID: 29624022
[TBL] [Abstract][Full Text] [Related]
5. Salinomycin inhibits canine mammary carcinoma
Du H; Zhou B; Zhang H; Jin Y; Zhang D; Lin D
Oncol Lett; 2017 Jul; 14(1):427-432. PubMed ID: 28693187
[TBL] [Abstract][Full Text] [Related]
6. Melatonin Treatment Combined with TGF-β Silencing Inhibits Epithelial- Mesenchymal Transition in CF41 Canine Mammary Cancer Cell Line.
Custódio PR; Colombo J; Ventura FV; Castro TB; Zuccari DAPC
Anticancer Agents Med Chem; 2020; 20(8):989-997. PubMed ID: 32264814
[TBL] [Abstract][Full Text] [Related]
7. Characterization of spheres derived from canine mammary gland adenocarcinoma cell lines.
Michishita M; Akiyoshi R; Yoshimura H; Katsumoto T; Ichikawa H; Ohkusu-Tsukada K; Nakagawa T; Sasaki N; Takahashi K
Res Vet Sci; 2011 Oct; 91(2):254-60. PubMed ID: 21190702
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of melatonin treatment in primary culture of canine mammary tumors.
Lopes JR; Maschio LB; Jardim-Perassi BV; Moschetta MG; Ferreira LC; Martins GR; Gelaleti GB; De Campos Zuccari DA
Oncol Rep; 2015 Jan; 33(1):311-9. PubMed ID: 25384569
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem-like sphere cells induced from de-differentiated hepatocellular carcinoma-derived cell lines possess the resistance to anti-cancer drugs.
Hashimoto N; Tsunedomi R; Yoshimura K; Watanabe Y; Hazama S; Oka M
BMC Cancer; 2014 Sep; 14():722. PubMed ID: 25260650
[TBL] [Abstract][Full Text] [Related]
10. 5-Fluorouracil may enrich cancer stem cells in canine mammary tumor cells
Zhou B; Jin Y; Zhang D; Lin D
Oncol Lett; 2018 May; 15(5):7987-7992. PubMed ID: 29755597
[TBL] [Abstract][Full Text] [Related]
11. Metabolite profiling in sphere-forming cells from canine mammary adenocarcinoma cell lines using gas chromatography-mass spectrometry.
Michishita M; Saito N; Nozawa S; Furumoto R; Nakagawa T; Sato T; Ochiai K; Azakami D; Katayama K; Nakahira R; Tazaki H; Machida Y; Ishiwata T
J Vet Med Sci; 2019 Sep; 81(9):1238-1248. PubMed ID: 31308293
[TBL] [Abstract][Full Text] [Related]
12. Effect of Melatonin in Epithelial Mesenchymal Transition Markers and Invasive Properties of Breast Cancer Stem Cells of Canine and Human Cell Lines.
Gonçalves Ndo N; Colombo J; Lopes JR; Gelaleti GB; Moschetta MG; Sonehara NM; Hellmén E; Zanon Cde F; Oliani SM; Zuccari DA
PLoS One; 2016; 11(3):e0150407. PubMed ID: 26934679
[TBL] [Abstract][Full Text] [Related]
13. The inhibitory effect of melatonin on mammary function of lactating dairy goats†.
Zhang W; Chen J; Zhao Y; Zheng Z; Song Y; Wang H; Tong D
Biol Reprod; 2019 Feb; 100(2):455-467. PubMed ID: 30346485
[TBL] [Abstract][Full Text] [Related]
14. Enhanced SLC34A2 in breast cancer stem cell-like cells induces chemotherapeutic resistance to doxorubicin via SLC34A2-Bmi1-ABCC5 signaling.
Ge G; Zhou C; Ren Y; Tang X; Wang K; Zhang W; Niu L; Zhou Y; Yan Y; He J
Tumour Biol; 2016 Apr; 37(4):5049-62. PubMed ID: 26546432
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of melatonin anticancer effects.
Hill SM; Frasch T; Xiang S; Yuan L; Duplessis T; Mao L
Integr Cancer Ther; 2009 Dec; 8(4):337-46. PubMed ID: 20050373
[TBL] [Abstract][Full Text] [Related]
16. mTOR pathway as a potential therapeutic target for cancer stem cells in canine mammary carcinoma.
Michishita M; Ochiai K; Nakahira R; Azakami D; Machida Y; Nagashima T; Nakagawa T; Ishiwata T
Front Oncol; 2023; 13():1100602. PubMed ID: 36816969
[TBL] [Abstract][Full Text] [Related]
17. CD44 and CD24 Expression and Prognostic Significance in Canine Mammary Tumors.
Rogez B; Pascal Q; Bobillier A; Machuron F; Lagadec C; Tierny D; Le Bourhis X; Chopin V
Vet Pathol; 2019 May; 56(3):377-388. PubMed ID: 30558511
[TBL] [Abstract][Full Text] [Related]
18. Meloxicam decreases the migration and invasion of CF41.Mg canine mammary carcinoma cells.
Iturriaga MP; Paredes R; Arias JI; Torres CG
Oncol Lett; 2017 Aug; 14(2):2198-2206. PubMed ID: 28781660
[TBL] [Abstract][Full Text] [Related]
19. Immunodetection of cells with a CD44+/CD24- phenotype in canine mammary neoplasms.
Magalhães GM; Terra EM; de Oliveira Vasconcelos R; de Barros Bandarra M; Moreira PR; Rosolem MC; Alessi AC
BMC Vet Res; 2013 Oct; 9():205. PubMed ID: 24119896
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors.
Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T
BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
